Chiba, Japan

Haruyoshi Honda


 

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 80(Granted Patents)


Location History:

  • Tomisatomura, JP (1985)
  • Tomisato, JP (1987 - 1989)
  • Tomisato-machi, JP (1998 - 2001)
  • Chiba, JP (1987 - 2005)

Company Filing History:


Years Active: 1985-2005

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Haruyoshi Honda: Innovator in Pharmaceutical Chemistry

Introduction

Haruyoshi Honda is a prominent inventor based in Chiba, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 12 patents to his name, he has made remarkable advancements in the field of drug development.

Latest Patents

Among his latest patents, one notable invention is related to imidazole derivatives or salts thereof, which are aimed at treating diseases induced by the overproduction of nitric oxide (NO) and interleukin-6 (IL-6). This invention includes a specific imidazole derivative represented by a complex formula, where various groups and atoms are defined to enhance its efficacy. Another significant patent involves a substituted piperidine derivative designed for treating urinary disturbances, showcasing his innovative approach to addressing medical needs.

Career Highlights

Throughout his career, Haruyoshi Honda has worked with reputable companies such as Ss Pharmaceutical Co., Ltd. and Ssp Co. Ltd. His work in these organizations has allowed him to develop and refine his inventions, contributing to advancements in pharmaceutical products.

Collaborations

Haruyoshi has collaborated with notable colleagues, including Susumu Sato and Hideaki Matsuda, which has further enriched his research and development efforts.

Conclusion

Haruyoshi Honda's innovative work in pharmaceutical chemistry, particularly in the development of imidazole and piperidine derivatives, highlights his significant impact on medical science. His contributions continue to pave the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…